Horm Metab Res 1986; 18(6): 411-414
DOI: 10.1055/s-2007-1012329
Clinical

© Georg Thieme Verlag, Stuttgart · New York

Evidence for an Inhibition of Thyroid Hormone Effects during Chronic Treatment with Amiodarone

P. Beck-Peccoz1 , A. Volpi2 , A. P. Maggioni2 , M. G. Cattaneo1 , G. Piscitelli1 , P. Giani2 , M. Landolina2 , G. Tognoni3 , G. Faglia1
  • 1Cattedra di Endocrinologia e Medicina Costituzionale, University of Milan, Milan, Italy
  • 2Divisione di Cardiologia, Magenta and Seriate Hospitals, Milan, Italy
  • 3Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy
Further Information

Publication History

1985

1985

Publication Date:
14 March 2008 (online)

Summary

The effects of chronic amiodarone treatment on several thyroid and cardiac function parameters were studied in 50 euthyroid patients with refractory ventricular arrhythmias, divided in responders and nonresponders according to their sensitivity to the antiarrhythmic action of the drug. No differences in the severity of cardiac disease and blood amiodarone concentrations were found in the two groups.

Amiodarone induced a significant inhibition of peripheral T4 monodeiodination, more pronounced in responders compared to nonresponders. On the contrary, only in responsive patients, elevated basal and TRH-stimulated TSH levels were observed (despite serum T3 levels were not different from those in nonresponders) and the indirect indices of cardiac performance, particularly the systolic time intervals, fell in a range usually observed in the hypothyroid states.

These findings suggest that amiodarone, besides the well-known inhibition of T4 to T3 conversion, also induces a partial resistance to the thyroid hormones, which is probably involved in the therapeutical effectiveness of the drug.